Aethlon Medical, Inc.
AEMD
$0.58
-$0.02-2.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 46.58% | -20.54% | 0.10% | -9.40% | -9.66% |
| Total Depreciation and Amortization | -4.71% | -38.80% | -31.11% | -5.27% | -5.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.22% | 939.67% | 428.44% | 371.48% | 327.89% |
| Change in Net Operating Assets | -893.91% | -3,007.77% | -249.79% | -210.67% | -80.45% |
| Cash from Operations | 8.46% | 18.95% | 20.76% | 18.97% | 24.52% |
| Capital Expenditure | -- | 107.04% | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 107.04% | 100.00% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -14.60% | 110.54% | 32.29% | -34.33% | 586.26% |
| Repurchase of Common Stock | 42.33% | 44.83% | 26.67% | 39.05% | 45.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.39% | -- | -- | -- | -- |
| Cash from Financing | -15.60% | 67.76% | 8.80% | -58.08% | 500.14% |
| Foreign Exchange rate Adjustments | 153.28% | -24.79% | -454.93% | -3,033.33% | -710.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -780.46% | 168.08% | 70.01% | -38.46% | 100.77% |